Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 70 | 61 | −9 |
| Shares | 31.5M | 33.3M | +1.80M (+5.7%) |
| Value | $1.04B | $513.8M | −$522.7M (−50.4%) |
New holders (15)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 1,166,952 | $18.0M | 5.61% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $11.1M | 1.04% |
| DAFNA Capital Management LLC | 100,000 | $1.55M | 0.32% |
| Renaissance Technologies LLC | 60,470 | $935.0K | 0.00% |
| Millennium Management LLC | 31,971 | $494.0K | 0.00% |
| Swiss National Bank | 28,000 | $433.0K | 0.00% |
| Maven Securities LTD | 25,184 | $390.0K | 0.04% |
| Prudential Financial Inc | 20,090 | $311.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 17,070 | $264.0K | 0.00% |
| Virtus ETF Advisers LLC | 13,706 | $212.0K | 0.09% |
| State of Wisconsin Investment Board | 12,265 | $190.0K | 0.00% |
| Two Sigma Investments, LP | 12,284 | $190.0K | 0.00% |
| Tarbox Family Office, Inc. | 1,000 | $15.0K | 0.00% |
| Advisor Group Holdings, Inc. | 250 | $4.00K | 0.00% |
| Parallel Advisors, LLC | 63 | $1.00K | 0.00% |
Sold out (24)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.